Protein quality control and the amyotrophic lateral sclerosis/frontotemporal dementia continuum

Hamideh Shahheydari, Audrey Ragagnin, Adam K. Walker, Reka P. Toth, Marta Vidal, Cyril J. Jagaraj, Emma R. Perri, Anna Konopka, Jessica M. Sultana, Julie D. Atkin

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Protein homeostasis, or proteostasis, has an important regulatory role in cellular function. Protein quality control mechanisms, including protein folding and protein degradation processes, have a crucial function in post-mitotic neurons. Cellular protein quality control relies on multiple strategies, including molecular chaperones, autophagy, the ubiquitin proteasome system, endoplasmic reticulum (ER)-associated degradation (ERAD) and the formation of stress granules (SGs), to regulate proteostasis. Neurodegenerative diseases are characterized by the presence of misfolded protein aggregates, implying that protein quality control mechanisms are dysfunctional in these conditions. Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are neurodegenerative diseases that are now recognized to overlap clinically and pathologically, forming a continuous disease spectrum. In this review article, we detail the evidence for dysregulation of protein quality control mechanisms across the whole ALS-FTD continuum, by discussing the major proteins implicated in ALS and/or FTD. We also discuss possible ways in which protein quality mechanisms could be targeted therapeutically in these disorders and highlight promising protein quality control-based therapeutics for clinical trials.

LanguageEnglish
Article number119
Pages1-25
Number of pages25
JournalFrontiers in Molecular Neuroscience
Volume10
DOIs
Publication statusPublished - 10 May 2017

Fingerprint

Quality Control
Proteins
Neurodegenerative Diseases
Endoplasmic Reticulum-Associated Degradation
Molecular Chaperones
Frontotemporal Dementia With Motor Neuron Disease
Protein Folding
Autophagy
Proteasome Endopeptidase Complex
Ubiquitin
Proteolysis
Homeostasis
Clinical Trials
Neurons

Bibliographical note

Copyright the Author(s) 2017. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

  • Amyotrophic lateral sclerosis (ALS)
  • Autophagy
  • Chaperones
  • Endoplasmic reticulum-associated degradation (ERAD)
  • Frontotemporal dementia (FTD)
  • Protein quality control
  • Ubiquitin-proteasome system (UPS)
  • Unfolded protein response

Cite this

@article{7ba4bbab34044f2da1139b5f813faaaa,
title = "Protein quality control and the amyotrophic lateral sclerosis/frontotemporal dementia continuum",
abstract = "Protein homeostasis, or proteostasis, has an important regulatory role in cellular function. Protein quality control mechanisms, including protein folding and protein degradation processes, have a crucial function in post-mitotic neurons. Cellular protein quality control relies on multiple strategies, including molecular chaperones, autophagy, the ubiquitin proteasome system, endoplasmic reticulum (ER)-associated degradation (ERAD) and the formation of stress granules (SGs), to regulate proteostasis. Neurodegenerative diseases are characterized by the presence of misfolded protein aggregates, implying that protein quality control mechanisms are dysfunctional in these conditions. Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are neurodegenerative diseases that are now recognized to overlap clinically and pathologically, forming a continuous disease spectrum. In this review article, we detail the evidence for dysregulation of protein quality control mechanisms across the whole ALS-FTD continuum, by discussing the major proteins implicated in ALS and/or FTD. We also discuss possible ways in which protein quality mechanisms could be targeted therapeutically in these disorders and highlight promising protein quality control-based therapeutics for clinical trials.",
keywords = "Amyotrophic lateral sclerosis (ALS), Autophagy, Chaperones, Endoplasmic reticulum-associated degradation (ERAD), Frontotemporal dementia (FTD), Protein quality control, Ubiquitin-proteasome system (UPS), Unfolded protein response",
author = "Hamideh Shahheydari and Audrey Ragagnin and Walker, {Adam K.} and Toth, {Reka P.} and Marta Vidal and Jagaraj, {Cyril J.} and Perri, {Emma R.} and Anna Konopka and Sultana, {Jessica M.} and Atkin, {Julie D.}",
note = "Copyright the Author(s) 2017. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.",
year = "2017",
month = "5",
day = "10",
doi = "10.3389/fnmol.2017.00119",
language = "English",
volume = "10",
pages = "1--25",
journal = "Frontiers in Molecular Neuroscience",
issn = "1662-5099",
publisher = "Frontiers Media S.A.",

}

Protein quality control and the amyotrophic lateral sclerosis/frontotemporal dementia continuum. / Shahheydari, Hamideh; Ragagnin, Audrey; Walker, Adam K.; Toth, Reka P.; Vidal, Marta; Jagaraj, Cyril J.; Perri, Emma R.; Konopka, Anna; Sultana, Jessica M.; Atkin, Julie D.

In: Frontiers in Molecular Neuroscience, Vol. 10, 119, 10.05.2017, p. 1-25.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Protein quality control and the amyotrophic lateral sclerosis/frontotemporal dementia continuum

AU - Shahheydari, Hamideh

AU - Ragagnin, Audrey

AU - Walker, Adam K.

AU - Toth, Reka P.

AU - Vidal, Marta

AU - Jagaraj, Cyril J.

AU - Perri, Emma R.

AU - Konopka, Anna

AU - Sultana, Jessica M.

AU - Atkin, Julie D.

N1 - Copyright the Author(s) 2017. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

PY - 2017/5/10

Y1 - 2017/5/10

N2 - Protein homeostasis, or proteostasis, has an important regulatory role in cellular function. Protein quality control mechanisms, including protein folding and protein degradation processes, have a crucial function in post-mitotic neurons. Cellular protein quality control relies on multiple strategies, including molecular chaperones, autophagy, the ubiquitin proteasome system, endoplasmic reticulum (ER)-associated degradation (ERAD) and the formation of stress granules (SGs), to regulate proteostasis. Neurodegenerative diseases are characterized by the presence of misfolded protein aggregates, implying that protein quality control mechanisms are dysfunctional in these conditions. Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are neurodegenerative diseases that are now recognized to overlap clinically and pathologically, forming a continuous disease spectrum. In this review article, we detail the evidence for dysregulation of protein quality control mechanisms across the whole ALS-FTD continuum, by discussing the major proteins implicated in ALS and/or FTD. We also discuss possible ways in which protein quality mechanisms could be targeted therapeutically in these disorders and highlight promising protein quality control-based therapeutics for clinical trials.

AB - Protein homeostasis, or proteostasis, has an important regulatory role in cellular function. Protein quality control mechanisms, including protein folding and protein degradation processes, have a crucial function in post-mitotic neurons. Cellular protein quality control relies on multiple strategies, including molecular chaperones, autophagy, the ubiquitin proteasome system, endoplasmic reticulum (ER)-associated degradation (ERAD) and the formation of stress granules (SGs), to regulate proteostasis. Neurodegenerative diseases are characterized by the presence of misfolded protein aggregates, implying that protein quality control mechanisms are dysfunctional in these conditions. Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are neurodegenerative diseases that are now recognized to overlap clinically and pathologically, forming a continuous disease spectrum. In this review article, we detail the evidence for dysregulation of protein quality control mechanisms across the whole ALS-FTD continuum, by discussing the major proteins implicated in ALS and/or FTD. We also discuss possible ways in which protein quality mechanisms could be targeted therapeutically in these disorders and highlight promising protein quality control-based therapeutics for clinical trials.

KW - Amyotrophic lateral sclerosis (ALS)

KW - Autophagy

KW - Chaperones

KW - Endoplasmic reticulum-associated degradation (ERAD)

KW - Frontotemporal dementia (FTD)

KW - Protein quality control

KW - Ubiquitin-proteasome system (UPS)

KW - Unfolded protein response

UR - http://www.scopus.com/inward/record.url?scp=85019207955&partnerID=8YFLogxK

UR - http://purl.org/au-research/grants/nhmrc/1006141

UR - http://purl.org/au-research/grants/nhmrc/1030513

UR - http://purl.org/au-research/grants/nhmrc/1086887

UR - http://purl.org/au-research/grants/nhmrc/1124005

UR - http://purl.org/au-research/grants/nhmrc/1036835

U2 - 10.3389/fnmol.2017.00119

DO - 10.3389/fnmol.2017.00119

M3 - Article

VL - 10

SP - 1

EP - 25

JO - Frontiers in Molecular Neuroscience

T2 - Frontiers in Molecular Neuroscience

JF - Frontiers in Molecular Neuroscience

SN - 1662-5099

M1 - 119

ER -